EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities

Ville Virtanen, Leena Saastamoinen, Maria Arvio, Hannu T Vesala, Sonja Miettinen, Antti Teittinen, Anna-Maija Tolppanen iD

Journal of Intellectual Disability Research · 2026

DOI: 10.1111/jir.70145 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Intellectual Disability Research, 2026. Verfasst von Ville Virtanen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Psychotropic Drugs, Polypharmacy, Persons with Intellectual Disabilities. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psychotropic use and psychotropic polypharmacy are common in people with intellectual disabilities, but representative population‐based studies on this topic are scarce. We evaluated the prevalence of psychotropic use and psychotropic polypharmacy in a Finnish nationwide cohort of people with intellectual disabilities aged 0–97 years.

Methods

The annual prevalence of psychotropic use in 2019 was studied among 37 196 individuals with intellectual disabilities and an age‐ and sex‐matched comparison cohort with no diagnosis of intellectual disabilities. Psychotropics included antipsychotics, antidepressants, anxiolytics, hypnotics and sedatives and antiepileptics indicated for bipolar disorder (carbamazepine, valproic acid, lamotrigine, pregabalin and clonazepam). Prevalence of interclass psychotropic polypharmacy (use from ≥ 2 different psychotropic groups) was evaluated in a 4‐month time window at the end of 2019.

Results

Prevalence of psychotropic use was higher in the intellectual disability cohort (42.3%) than comparison cohort (15.0%). Antipsychotics were the most common psychotropic group in the intellectual disability cohort (28%), with lower prevalence in the comparison cohort (3.3%). The prevalence of antidepressant use was 19.4% in the intellectual disability cohort and 9.7% in the comparison cohort. A likely indication was identified for 52.9% of psychotropic users with intellectual disability (major psychiatric comorbidity 38.1%, challenging behaviour 22.1%). Psychotropic polypharmacy was more common in the intellectual disability cohort (18.2%), than in the comparison cohort (3.6%).

Conclusions

Our findings highlight concerns about psychotropic polypharmacy and potential overmedication. Using a comprehensive, nationwide cohort, this study emphasises the need for more evidence‐based, person‐centred approaches, including careful diagnostics, non‐pharmacological interventions and regular treatment reviews.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotropic DrugsPolypharmacyPersons with Intellectual DisabilitiesPrevalenceFinlandCohort StudiesHumansMaleFemaleInfant, NewbornInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and over

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Research and Information Section, Development and Information Services, Finnish Medicines Agency Fimea, Helsinki, Finland.
  • Päijät-Häme Joint Municipal Authority, Neurology, Lahti, Finland.
  • Finnish Association for Intellectual Disabilities, Helsinki, Finland.
  • The Research Unit, The Social Insurance Institution of Finland, Helsinki, Finland.

ORCID-Profile: Anna-Maija Tolppanen

Zitieren

APA

Virtanen, V., Saastamoinen, L., Arvio, M., Vesala, H. T., Miettinen, S., Teittinen, A., & Tolppanen, A. M. (2026). Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.70145

Vancouver

Virtanen V, Saastamoinen L, Arvio M, Vesala HT, Miettinen S, Teittinen A, et al. Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities. Journal of Intellectual Disability Research. 2026. doi:10.1111/jir.70145

BibTeX
@article{Virtanen2026,
  author = {Virtanen, Ville and Saastamoinen, Leena and Arvio, Maria and Vesala, Hannu T and Miettinen, Sonja and Teittinen, Antti and Tolppanen, Anna-Maija},
  title = {Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities},
  journal = {Journal of Intellectual Disability Research},
  year = {2026},
  doi = {10.1111/jir.70145}
}
Kostenlos starten →